469.20001 EUR
6.4
1.35%
Last update Dec 16, 9:55 PM CET
Main market
Day range
463.5
471.10001
Previous close
475.60001
Open
471.10001
Access this stock data via API
Subscribe
Madrigal Pharmaceuticals, Inc.
469.20
6.40
1.35%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 153.5M 0 0 0
Cost of revenue 5.3M
Gross profit 148.2M
Operating expense
Research & development 201.7M 272.4M 245.4M 205.2M
Selling general and admin 370.8M 108.1M 48.1M 37.3M
Other operating expenses
Operating income -424.3M -380.5M -293.6M -242.5M
Non operating interest income
Income 39.8M 19.6M 2.2M 363K
Expense 12.5M 12.7M 4.0M 0
Other income expense 273K
Pretax income -397.1M -373.6M -295.4M -241.8M
Tax provision
Net income -397.1M -373.6M -295.4M -241.8M
Basic EPS -21.9 -20.0 -17.2 -14.6
Diluted EPS -21.9 -20.0 -17.2 -14.6
Basic average shares 18.1M 19.6M 17.6M 17.0M
Diluted average shares 18.1M 19.6M 17.6M 17.0M
EBITDA -383.6M -360.4M -290.9M -241.4M
Net income from continuing op. -397.1M -373.6M -295.4M -241.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 11 hours 24 minutes

10:35
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).